Mondelo, Manolito M.
HRN: 26-19-88 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
11/21/2024
11/28/2024
IV DRIP
500mg
OD
Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes